Old Web
English
Sign In
Acemap
>
Paper
>
Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)
Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)
2019
Efstathios Kastritis
Ioanna Dialoupi
Maria Gavriatopoulou
Maria Roussou
Nikolaos Kanellias
Despina Fotiou
Ioannis Ntanasis-Stathopoulos
Elektra Papadopoulou
Dimitrios C. Ziogas
Kimon Stamatelopoulos
Efstathios Manios
Argyrios Ntalianis
Evangelos Eleutherakis-Papaiakovou
Asimina Papanikolaou
Magdalini Migkou
Charikleia Gakiopoulou
Erasmia Psimenou
M. E. Tselegkidi
Ourania Tsitsilonis
Ioannis Trougakos
Ioannis Kostopoulos
Evangelos Terpos
Meletios A. Dimopoulos
Keywords:
Bortezomib/lenalidomide
AL amyloidosis
Immunology
Cancer research
Medicine
Immunoglobulin light chain
Dexamethasone
Internal medicine
Oncology
primary treatment
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]